BIOVIE INC.
BIVI$32M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCARSON CITY
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
3
Next Catalyst
This month
Market Overview
Stock performance and key metrics
BIVI News
Catalyst Timeline
3 upcoming, 0 past
Phase 2Next
NE3107 Phase 2 Est. Readout
June 2026~EstimatedNE3107208
Primary completion for NE3107 trial (NCT06847191) in Long COVID
Source2 more catalysts beyond 14 days
Start a 7-day free trial to see all upcoming catalysts
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NE3107 | Phase 3 | Parkinsons Disease (PD) | - | - |
Terlipressin acetate continuous infusion | Phase 2 | Cirrhosis | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply